PFAS Exposure and Metabolic Disorders: Mechanistic Insights into Lipid and Glucose Homeostasis
Biomolecules · 2026
DOI: 10.3390/biom16071056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Xinyi Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health, Zhejiang Provincial Center for Disease Control and Prevention, 3399 Bin Sheng Road, Binjiang District, Hangzhou 3…. Hauptthemen laut MEDLINE: Glucose, Lipid Metabolism, Fluorocarbons, Metabolic Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Disease Prevention and Control Innovation Team of Zhejiang Province, Zhejiang Provincial Natural Science Foundation.
Abstract (Originalsprache)
Per- and polyfluoroalkyl substances (PFAS) are a class of synthetic fluorinated chemicals characterized by high environmental persistence and widespread occurrence, which have attracted increasing attention due to their potential adverse effects on human health. As the global burden of chronic diseases related to lipid and glucose dysregulation rises, identifying environmental contributors is increasingly important. Growing evidence links PFAS exposure to metabolic disorders, particularly those involving lipid and glucose metabolism. This review summarizes current findings on the mechanisms by which PFAS disrupt metabolic balance, with a focus on pathways involved in fatty acid uptake and oxidation, nuclear receptor signaling, oxidative stress, inflammation and insulin signaling. Furthermore, we highlight the convergence of molecular pathways involved in PFAS-induced lipid and glucose metabolic alterations, which may provide a mechanistic basis for understanding the development of metabolic disorders. Finally, we discuss current research limitations and future perspectives, including the potential application of computational approaches and emerging technologies to further elucidate PFAS-related metabolic effects. A comprehensive understanding of these mechanisms may help identify targets for the prevention and treatment of metabolic diseases, including obesity and type 2 diabetes, and provide regulatory policies on PFAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental Health, Zhejiang Provincial Center for Disease Control and Prevention, 3399 Bin Sheng Road, Binjiang District, Hangzhou 310051, China.
- School of Public Health, Health Science Center, Ningbo University, Ningbo 315211, China.
ORCID-Profile: Simeng Gu, Zhe Mo, Zhijian Chen, Sujun Yan
Förderung
- National Natural Science Foundation of China
- Disease Prevention and Control Innovation Team of Zhejiang Province
- Zhejiang Provincial Natural Science Foundation
Zitieren
APA
Chen, X., Wen, W., Gu, S., Guo, F., Mo, Z., Chen, Z., Yan, S., & Wang, X. (2026). PFAS Exposure and Metabolic Disorders: Mechanistic Insights into Lipid and Glucose Homeostasis. Biomolecules. https://doi.org/10.3390/biom16071056
Vancouver
Chen X, Wen W, Gu S, Guo F, Mo Z, Chen Z, et al. PFAS Exposure and Metabolic Disorders: Mechanistic Insights into Lipid and Glucose Homeostasis. Biomolecules. 2026. doi:10.3390/biom16071056
BibTeX
@article{Chen2026,
author = {Chen, Xinyi and Wen, Weijing and Gu, Simeng and Guo, Fanjia and Mo, Zhe and Chen, Zhijian and Yan, Sujun and Wang, Xiaofeng},
title = {PFAS Exposure and Metabolic Disorders: Mechanistic Insights into Lipid and Glucose Homeostasis},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16071056}
}
EUVIMED